| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.19 | 0.06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |